IRDAI gives its no-objection to Religare's application proposing the company's takeover by Burman family. The go-ahead is the ...
Religare Enterprises Ltd faces corporate control battle as RBI refuses approval for Rakesh Asthana as Director.
Religare’s management, led by its chairperson Rashmi Saluja, and the Burman family-controlled firms are locked in a battle to ...
In a notice to the stock exchanges, the company said Religare is currently an acquisition target, and an open offer was made ...
On August 22, the RoC granted Religare a three-month extension, postponing the company's 40th AGM from September 30 to ...
The stock has rebounded from the neckline of its prior consolidation range, which also aligns with the support zone of its ...
In a conversation with Business Today, Ravi Singh, Senior Vice President (SVP)—Retail Research at Religare Broking, shared ...
Rashmi Saluja secured enough votes to be reappointed as the chair of Care Health Insurance, which is owned by Religare ...
Religare Retail Research recommended accumulate rating on UltraTech Cement with a target price of Rs 11,446 in its research report dated October 23 2024.
Religare Retail Research recommended accumulate rating on Infosys with a target price of Rs 2041 in its research report dated October 18 2024.
The events will be held as part of the Finacial Expo..Financial Expo Kottayam. Sampadyam Financial Expo. Share Market Seminar ...
BENGALURU (Reuters) -India's markets regulator has asked Religare Enterprises to apply for approvals to let the billionaire Burman family buy more shares in the financial services company, dealing a ...